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An epithelial–mesenchymal cell transformation (EMT) occurs during the development of endocardial cushions in the
atrioventricular (AV) canal of the heart. This is a complex developmental process regulated by multiple extracellular signals
and signal transduction pathways. It was recently shown that the transcription factor Slug is expressed in the AV canal and
is required for initial steps of EMT. Treatment of AV canal explants with either antisense oligodeoxynucleotides toward
Slug or anti-TGFb2 antibody inhibited initial steps of EMT. Others have identified roles for HGF and BMP during EMT in
he heart. Both HGF and BMP are known to regulate Slug in other cell types. To determine whether TGFb2 or other
ignaling factors regulate Slug expression during EMT in the heart, we cultured AV canal explants in the presence of
nti-TGFb2 antibody, anti-TGFb3 antibody, pertussis toxin, retinoic acid, noggin, or anti-HGF antibody. Only treatment
with anti-TGFb2 antibody or retinoic acid inhibited Slug expression in AV canal explants. Consistent with these data, we
found that retinoic acid disrupted initial steps of EMT, while antagonists of BMP and HGF signaling disrupted later steps
of EMT. Transfection of AV canal explants with Slug rescued the inhibitory effect of anti-TGFb2 antibody but not retinoic
cid on EMT. Slug is thus an essential target of TGFb2 signaling during EMT in the developing chicken heart.
© 2000 Academic Press
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formation; zinc finger protein.Slug is expressed by AV canal endothelial cells, as well as byINTRODUCTION
Early in embryonic development, the vertebrate heart is a
hollow tube composed of an outer layer of myocardium and
an inner layer of endocardium separated by extracellular
matrix (ECM). As cardiac morphogenesis proceeds, endocar-
dial cushions develop within the atrioventricular (AV) ca-
nal. The endocardial cushions initially consist only of ECM
(Krug et al., 1987). Later, in response to an inductive signal
emitted by AV canal myocardium (Runyan and Markwald,
1983; Krug et al., 1985, 1987), a portion of the endothelial
cells lining the endocardial cushions undergo an epithelial–
mesenchymal cell transformation (EMT) and migrate into
the underlying ECM (Kinsella and Fitzharris, 1980). Endo-
cardial cushion tissue eventually contributes to the leaflets
of the mitral and tricuspid valves, as well as to the inter-
atrial and interventricular septa (Markwald et al., 1984;
Chin et al., 1992). Therefore, the study of EMT is critical to
understanding how certain heart defects arise in humans.
The zinc finger protein Slug is a member of the Snail
family of related transcription factors (Nieto et al., 1994).
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All rights of reproduction in any form reserved.mesenchymal cells within the endocardial cushions. In
vitro experiments demonstrated that Slug is required for AV
canal endothelial cells to undergo initial steps of EMT.
Treatment of chicken AV canal explants with antisense
Slug oligodeoxynucleotides inhibited mesenchymal cell
formation. Specifically, antisense treatment prevented en-
dothelial cell–cell separation, suggesting that Slug acts
early in the EMT pathway (Romano and Runyan, 1999).
Slug also is required for the EMTs that occur during
gastrulation and neural crest differentiation in chicken
embryos. Epiblast cells flanking the primitive streak ex-
press Slug as they transform into mesenchymal cells and
migrate down into the blastocoel during gastrulation. Pre-
sumptive neural crest cells express Slug as they transform
into mesenchymal cells and migrate from the dorsal region
of the neural tube. When stage 4–9 chicken embryos were
cultured in vitro in the presence of antisense Slug oligode-
oxynucleotides, mesoderm formation was impaired. Like-
wise, presumptive neural crest cells failed to transform into
mesenchyme, resulting in a wide range of defects (Nieto et
al., 1994). It has been proposed that Slug regulates the
expression of genes required for the changes in cell adhesion
and cytoskeletal organization necessary for epithelial cells
to transform into migratory mesenchymal cells. Slug also91
may play a role in maintaining the mesenchymal cell
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92 Romano and Runyanphenotype in tissues such as the limb bud (Buxton et al.,
997; Ros et al., 1997).
Several signaling factors are good candidates for regulat-
ng Slug expression in the heart. For instance, TGFb2, a
member of a large superfamily of related growth factors, is
expressed in both AV canal myocardium and endocardium
(Potts et al., 1992; Boyer et al., 1999a). Treatment of AV
anal explants with anti-TGFb2 antibody inhibited initial
steps of EMT including endothelial cell–cell separation
(Boyer et al., 1999a). Gi proteins regulate intracellular
ignaling events by inhibiting adenylate cyclase in response
o activation of a G-protein-linked receptor. Treatment of
V canal explants with pertussis toxin, an antagonist of Gi
protein signaling, also inhibited initial steps of EMT (Run-
yan et al., 1990; Boyer et al., 1999a). In contrast, treatment
of AV canal explants with anti-TGFb3 antibody inhibited
later steps of EMT including mesenchymal cell migration
(Boyer et al., 1999a).
Retinoic acid also is a candidate for regulating Slug
expression in the heart, although an endogenous source of
retinoic acid is unknown. Mice exposed to inappropriate
levels of retinoic acid, or which have a null mutation for the
retinoid X receptor-alpha (RXRa), exhibit AV septal defects
(Gruber et al., 1996; reviewed by Smith et al., 1998). BMPs
and HGF have been shown to regulate AV canal develop-
ment and therefore, may regulate Slug expression as well. It
appears that BMP2 and TGFb3 act synergistically to medi-
te certain steps of EMT in the AV canal (Yamagishi et al.,
999; Nakajima et al., 2000). HGF appears to regulate
esenchymal cell migration (Song et al., 1999). It is espe-
ially important to consider BMPs and HGF as candidates
or regulating Slug expression in the heart since these
rowth factors have been shown to regulate Slug expression
n other tissues (Liem et al., 1995; Savagner et al., 1997;
elleck et al., 1998).
To identify specific signaling factors that regulate Slug
xpression during EMT in the heart, we cultured AV canal
xplants in the presence of anti-TGFb2 antibody, anti-
TGFb3 antibody, pertussis toxin, retinoic acid, noggin, or
nti-HGF antibody. Semiquantitative RT-PCR and immu-
ostaining demonstrated that only treatment with anti-
GFb2 antibody or retinoic acid inhibited Slug expression
n AV canal explants. Consistent with these data, we found
hat treatment of AV canal explants with retinoic acid
nhibited initial steps of EMT in a dose-dependent manner.
reatment of explants with noggin (an antagonist of BMP
ignaling) or anti-HGF antibody inhibited later steps of
MT. Addition of exogenous BMP-2 or HGF rescued the
nhibitory effects of noggin or anti-HGF antibody, respec-
ively, on transformation.
Transfection of AV canal explants with Slug rescued the
nhibitory effect of anti-TGFb2 antibody but not retinoic
acid on EMT. Therefore, Slug is an essential target of
TGFb2 signaling during EMT in the developing chicken
eart. We speculate that TGFb2 regulates Slug expression
via activation of the Type III TGFb receptor, which isCopyright © 2000 by Academic Press. All rightuggest that Slug was not sufficient to overcome the inhibi-
ory effect of retinoic acid on EMT because it is only one of
everal genes in the heart disrupted by retinoic acid exposure.
MATERIALS AND METHODS
Treatment of AV Canal Explants with Signaling
Factors or Signaling Factor Antagonists
Collagen gels were prepared according to Potts and Runyan
(1989): 1 ml of rat tail collagen (approximately 3.5 mg/ml) diluted
1:1 in water was mixed with 200 ml of 2.2% sodium bicarbonate
(Sigma, St. Louis, MO) diluted 1:1 in 103 Medium 199 (Gibco BRL,
aithersburg, MD). Two hundred eighty microliters of the collagen
olution was poured into each well of a Nunclon MultiDish culture
ish (Nunc, Roskilde, Denmark) and allowed to solidify for at least
5 min at room temperature. Five hundred microliters of medium
as applied to the collagen gels for at least 1 h at 37°C in a tissue
ulture incubator prior to use.
Fertilized White Leghorn chicken eggs (Rosemary’s Farm, Santa
onica, CA) were incubated at 37°C to obtain embryos, which
ere staged according to Hamburger and Hamilton (1951). AV
anals were dissected from embryonic chicken hearts in Tyrode’s
olution (Sigma) and cut open to expose the inner endocardial
urface. The explants were placed on collagen gels so that the
ndocardium was in contact with the surface of the gel to facilitate
ndothelial cell outgrowth. After approximately 6 h of incubation
t 37°C in a tissue culture incubator, the following signaling factors
r signaling factor antagonists were applied to the explants: poly-
lonal anti-chicken TGFb2 antibody (R&D Systems, Minneapolis,
MN) (10 mg/ml) diluted in 300 ml of Medium 199, 300 ml of
onoclonal anti-chicken TGFb3 antibody supernatant (Develop-
mental Studies Hybridoma Bank, University of Iowa), pertussis
toxin (Sigma) (10 ng/ml) diluted in 300 ml of Medium 199, retinoic
cid (Sigma) (10 ng/ml) diluted in 300 ml of Medium 199, 300 ml of
noggin-containing or control conditioned medium diluted 1:1 in
Medium 199, or a polyclonal anti-human HGF antibody (R&D
Systems) (10 mg/ml). Conditioned medium was prepared using
parental Chinese hamster ovary (CHO) cells or CHO cells stably
expressing Xenopus noggin (Smith and Harland, 1992). Dr. Richard
Harland (University of California at Berkeley) kindly provided
CHO cells. A range of retinoic acid concentrations was tested
(0.5–300 ng/ml) (data not shown). Retinoic acid at a concentration
of 10 ng/ml proved to most effectively inhibit EMT without any
visible signs of toxicity.
After 24 h of incubation, the number of mesenchymal cells
within the collagen gel was counted for each explant under an
Olympus inverted microscope. Observation under the microscope
revealed that both control and treated explants were viable and that
the myocardium was beating. A t test, two-sample assuming
nequal variances, was performed to compare control and treated
roups of explants (Microsoft Excel software).
Semiquantitative RT-PCR
After 24 h of incubation, total RNA was extracted from selected
AV canal explants using RNA Stat-60 (Tel-Test “B”, Inc., Friends-
wood, TX) and treated with DNase (Gibco BRL). RT-PCR was then
performed. The total volume for each reverse transcription reaction
was 30 ml for 2 mg of RNA. The reaction also included 1.5 ml of
andom primers (Gibco BRL), 1 ml of 10 mM dNTPs (Gibco BRL), 20s of reproduction in any form reserved.
U of rRNasin RNase inhibitor (Promega, Madison, WI), and 400 U
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93Slug and TGFb2 in the Heartof M-MLV reverse transcriptase in 53 First Strand Buffer supplied
with the enzyme (Gibco BRL). cDNA was synthesized in a PTC-
100 programmable thermal controller (MJ Research, Inc., Water-
town, MA) under the following conditions: a 1.5-h incubation at
37°C and a 10-min incubation at 75°C.
Specific primers were designed to amplify a 358-bp Slug se-
quence by PCR. The primer sequences were 59 CTGCCT-
TCAAAATGCCAC (bp 1–14) and 39 TTGGACTGGATTCTCTCT
(bp 341–358). The total volume for each PCR was 50 ml. The
reaction included 0.1 mg of each specific primer (Integrated DNA
echnologies, Inc., Coralville, IA), 0.1 mg of cDNA, 1 ml of 10 mM
dNTPs (Gibco), 3 ml of 25 mM magnesium chloride (Fisher Scien-
ific, Pittsburgh, PA), and 2.5 U of Taq DNA Polymerase in 103
ssay Buffer B supplied with the enzyme (Fisher Scientific). PCR
as performed in a PTC-100 programmable thermal controller
nder the following conditions: 30 s denaturation at 92°C, 1 min
nnealing at 58°C, and 1.5 min extension at 72°C. As a control for
oading, RT-PCR also was performed using specific primers de-
igned to amplify an 800-bp glyceraldehyde-3-phosphate dehydro-
enase (GAPDH) sequence.
The PCR products were fractionated on a 1% agarose gel and
isualized using ethidium bromide. Band densities were quanti-
ated using NIH Image analysis software. The background density
f the gel was subtracted from the peak density for each band. The
rea of each band measured was then multiplied by the adjusted
and density to determine relative amplification levels. Twenty-
even cycles was determined to be within the linear range of both
lug and GAPDH amplification by removing and analyzing ali-
quots from a series of cycles (20–35). RT-PCR was then repeated for
27 cycles using RNA collected from both control and treated
explants. Slug and GAPDH band densities were quantitated using
NIH Image analysis software as described above. Slug band densi-
ties were normalized to GAPDH levels in the same RNA samples.
The RT-PCR experiment was performed four times and average
Slug band densities were obtained. The average Slug band densities
obtained from treated AV canal explants were plotted relative to
the average Slug band density obtained from control AV canal
explants, which was arbitrarily set at 1.
Immunostaining of AV Canal Explants
After 24 h of incubation, selected AV canal explants were rinsed
with Tyrode’s solution for 30 min at room temperature and fixed
with 2% paraformaldehyde overnight at 4°C. After fixation, the
explants were rinsed with 13 PBS for 1 h at room temperature. To
block nonspecific binding sites, 13 PBS containing 1% bovine
erum albumin (Sigma) and 2% donkey serum (Jackson Im-
unoResearch Laboratories, Inc., West Grove, PA) was applied to
he explants for 30 min at 37°C. Blocking solution containing 0.2%
ween (Sigma) was then applied to the explants overnight at 4°C.
monoclonal anti-chicken Slug antibody (Developmental Studies
ybridoma Bank) was diluted 1:100 in 13 PBS containing 0.5%
ovine serum albumin, 1% donkey serum, and 0.2% Tween and
pplied to the explants for 2 h at 4°C. Alternatively, mouse IgG
Jackson ImmunoResearch Laboratories, Inc.) (1 mg/ml) diluted in
3 PBS containing 0.5% bovine serum albumin, 1% donkey serum,
nd 0.2% Tween was applied to some of the explants as a negative
ontrol. After incubation with the primary antibody, the explants
ere rinsed with 13 PBS containing 0.2% Tween for 2 h at room
emperature. AffiniPure rabbit anti-mouse IgG (H1L) (Jackson
mmunoResearch Laboratories, Inc.) (10 mg/ml) was diluted in 13
BS containing 0.2% Tween and applied to the explants for 30 minCopyright © 2000 by Academic Press. All rightere rinsed as previously described. Finally, Cy5-conjugated Af-
niPure goat anti-rabbit IgG (H1L) (Jackson ImmunoResearch
aboratories, Inc.) was diluted 1:300 in 13 PBS containing 0.2%
ween and applied to the explants for 45 min at 4°C. After
ncubation with the tertiary antibody, the explants were rinsed
ith 13 PBS containing 0.2% Tween for 2 h at room temperature
nd then with 13 PBS for 30 min at room temperature. After the
xplants were rinsed with water, the collagen gels were transferred
o glass slides. Coverslips were mounted using glycerol gelatin and
ealed with nail polish. The slides were stored in the dark at 4°C
ntil viewed under a Leica confocal microscope.
Transfection of AV Canal Explants with Slug cDNA
Full-length chicken Slug cDNA (provided by Dr. Thomas Jessell
at Columbia University, New York) was cloned into pIRES2-EGFP
vector (Clontech, Palo Alto, CA) using EcoRI and BamHI restric-
tion enzymes (Gibco BRL). A mixture of plasmid DNA and Lipo-
fectamine reagent (Gibco BRL) was prepared as follows: 12 mg of
plasmid DNA (pIRES2-EGFP or Slug-pIRES2-EGFP) was diluted in
100 ml of Medium 199 (Gibco BRL). Twelve microliters of Lipo-
fectamine reagent was also diluted in 100 ml of Medium 199. The
plasmid DNA and Lipofectamine reagent solutions were mixed and
incubated for 15 min at room temperature. An additional 800 ml of
Medium 199 was then added to the mixture.
Collagen gels were prepared as described above. AV canals were
dissected from stage 14 embryonic chicken hearts in Tyrode’s
solution (Sigma) and cut open to expose the inner endocardial
surface. The explants were incubated in the mixture of plasmid
DNA and Lipofectamine reagent for 30 min at 37°C in a tissue
culture incubator. After 30 min of incubation, the explants were
placed on collagen gels and returned to the tissue culture incubator.
After approximately 6, 18, and 30 h of incubation, a polyclonal
anti-chicken TGFb2 antibody (R&D Systems) (10 mg/ml) or reti-
noic acid (Sigma) (10 ng/ml) diluted in 300 ml of Medium 199 was
applied to the explants. After 48 h of incubation, the number of
mesenchymal cells within the collagen gel was counted for each
explant under an Olympus inverted microscope. Observation un-
der the microscope revealed that transfected explants were viable
and that the myocardium was beating. A t test, two-sample
assuming unequal variances, was performed to compare control
and treated groups of explants (Microsoft Excel software).
RESULTS
Retinoic Acid Inhibits Initial Steps of Epithelial–
Mesenchymal Cell Transformation
The transcription factor Slug is expressed in the AV canal
and is required for initial steps of EMT. Slug expression
within AV canal endocardium appears to be an early re-
sponse to a signal emitted by AV canal myocardium (Ro-
mano and Runyan, 1999). Previous studies have implicated
several signaling factors including TGFb2, TGFb3, BMP,
and HGF as components of the inductive signal (Potts et al.,
1992; Boyer et al., 1999a; Song et al., 1999; Yamagishi et al.,
1999). TGFb2 is required along with Slug for initial steps of
EMT, whereas TGFb3 is required for later steps of EMT
(Boyer et al., 1999a). In this study, we performed experi-
ments to determine if BMP and HGF are required fors of reproduction in any form reserved.
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retinoic acid on EMT. Signaling factors required for initial
steps of EMT were hypothesized to be good candidates for
regulating Slug expression in the heart.
AV canals were dissected from Hamburger and Hamilton
(1951) stage 14 chicken embryos and cultured on collagen
gels in medium containing retinoic acid. After 24 h of
incubation, the number of mesenchymal cells beneath the
surface of the collagen gel was counted for each explant.
Treatment of explants with retinoic acid resulted in a
statistically significant decrease in mesenchymal cell for-
mation compared to untreated explants (Fig. 1). Specifically,
retinoic acid treatment resulted in approximately 63%
fewer mesenchymal cells than untreated explants.
Retinoic acid interfered with initial steps of EMT, includ-
ing endothelial cell–cell separation. That is, the AV canal
endothelial cells of retinoic acid-treated explants (Fig. 2I)
were smaller and remained in tight contact with one
another compared to the AV canal endothelial cells of
control explants (Fig. 2A). In addition, fewer mesenchymal
cells were observed within the collagen gel (Fig. 2J).
We attempted to rescue the inhibitory effect of retinoic
acid on EMT by adding exogenous TGFb2. AV canals were
dissected from stage 14 chicken embryos and cultured on
collagen gels in medium containing both retinoic acid and
TGFb2. After 24 h of incubation, the number of mesenchy-
al cells within the collagen gel was counted for each
xplant. Treatment of explants with a combination of
FIG. 1. Retinoic acid inhibited initial steps of epithelial–
mesenchymal cell transformation. Stage 14 AV canal explants were
cultured on collagen gels in the presence of retinoic acid. After 24 h
of incubation, the number of mesenchymal cells within the colla-
gen gel was counted for each explant. Treatment of explants with
retinoic acid resulted in a statistically significant (P , 0.05)
decrease in mesenchymal cell formation compared to untreated
explants. Error bars indicate the standard errors (N . 10).Copyright © 2000 by Academic Press. All rightal cell formation compared to explants treated only with
etinoic acid (Fig. 3). Therefore, TGFb2 was not sufficient to
vercome the inhibitory effect of retinoic acid on EMT.
Noggin, an Antagonist of BMP Signaling, Inhibits
Later Steps of Epithelial–Mesenchymal Cell
Transformation
Previous work suggests that BMP signaling is required for
EMT in the heart (Yamagishi et al., 1999). Therefore, we
tested the effect of noggin, an antagonist of BMP signaling,
on EMT. AV canals were dissected from stage 13, 14, 15, or
16 chicken embryos and cultured on collagen gels in
noggin-containing or control conditioned medium. After
24 h of incubation, the number of mesenchymal cells
within the collagen gel was counted for each explant.
Noggin had no significant effect on mesenchymal cell
formation in stage 13, 14, or 15 explants. However, treat-
ment of stage 16 explants with noggin resulted in a statis-
tically significant decrease in mesenchymal cell formation
compared to untreated explants or explants cultured in
control conditioned medium (Fig. 4). Specifically, treatment
of stage 16 explants with noggin resulted in approximately
30% fewer mesenchymal cells than explants cultured in
control conditioned medium. The inhibitory effect of nog-
gin on stage 16 explants was rescued by the addition of
exogenous BMP-2 (Fig. 4).
The AV canal endothelial cells of both control (Figs. 2A
and 2E) and noggin-treated (Fig. 2C) stage 16 explants
formed a large monolayer on the surface of the collagen gel
and eventually separated from one another. However, sig-
nificantly fewer mesenchymal cells were observed within
the collagen gel in the presence of noggin (Fig. 2D) com-
pared to control explants (Figs. 2B and 2F). Therefore, BMP
signaling appears to be required only for later steps of EMT
such as mesenchymal cell migration. This is supported by
the finding that noggin had no discernible effect on stage 13,
14, or 15 explants, although AV canal endothelial cells
begin to receive an inductive signal from AV canal myocar-
dium as early as stage 131 (Ramsdell and Markwald, 1998).
Anti-HGF Antibody Inhibits Later Steps of
Epithelial–Mesenchymal Cell Transformation
HGF signaling also may be required for AV canal endothe-
lial cells to undergo EMT (Song et al., 1999). AV canals were
dissected from Hamburger and Hamilton (1951) stage 14, 15,
16, or 17 chicken embryos and cultured on collagen gels in
medium containing anti-HGF antibody. After 24 h of incuba-
tion, the number of mesenchymal cells within the collagen
gel was counted for each explant. The anti-HGF antibody had
no effect on mesenchymal cell formation in stage 14, 15, or 16
explants. However, treatment of stage 17 explants with anti-
HGF antibody resulted in a statistically significant decrease in
mesenchymal cell formation compared to untreated explants
(Fig. 5). Specifically, treatment of stage 17 explants with
anti-HGF antibody resulted in approximately 28% fewer mes-s of reproduction in any form reserved.
(
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95Slug and TGFb2 in the Heartenchymal cells than in untreated explants. The inhibitory
effect of the anti-HGF antibody on stage 17 explants was
rescued by the addition of exogenous HGF (Fig. 5).
FIG. 2. Retinoic acid inhibited initial steps of epithelial–mesenchy
noggin and anti-HGF antibody inhibited later steps of epithelial–m
(endothelial cells, A, C, E, G, I; mesenchymal cells, B, D, F, H, J). The
noggin-containing (G) or control (E) conditioned medium, or expla
separation. In contrast, the AV canal endothelial cells of explants treat
mesenchymal cells were observed beneath the surface of the collag
anti-HGF antibody (J), compared to untreated explants (B) or explantsCopyright © 2000 by Academic Press. All rightThe AV canal endothelial cells of both control explants
Fig. 2A) and explants treated with anti-HGF antibody (Fig.
G) formed a large monolayer on the surface of the collagen
cell transformation including endothelial cell–cell separation, while
chymal cell transformation including mesenchymal cell migration
canal endothelial cells of untreated explants (A), explants cultured in
treated with anti-HGF antibody (I) exhibited endothelial cell–cell
th retinoic acid remained in tight contact with one another (C). Fewer
l when explants were treated with retinoic acid (D), noggin (H), or
ured in control conditioned medium (F).mal
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96 Romano and Runyangel and eventually separated from one another. However,
significantly fewer mesenchymal cells were observed
within the collagen gel when stage 17 explants were treated
with anti-HGF antibody (Fig. 2H) compared to control
explants (Fig. 2B). Therefore, like BMP, HGF may be re-
quired only for later steps of EMT such as mesenchymal
cell migration. This is supported by the finding that the
anti-HGF antibody had no discernible effect on stage 14, 15,
or 16 explants.
Anti-TGFb2 Antibody or Retinoic Acid Inhibits
lug Expression in AV Canal Explants
To determine if TGFb2 or possibly other signaling factors
egulate Slug expression during EMT in the heart, we
ultured AV canal explants on collagen gels in the presence
f anti-TGFb2 antibody, anti-TGFb3 antibody, pertussis
oxin, retinoic acid, noggin, or anti-HGF antibody. RNA
as collected after 24 h of incubation and used to perform
emiquantitative RT-PCR. Specifically, RT-PCR was per-
ormed using specific primers designed to amplify a 358-bp
lug sequence or an 800-bp GAPDH sequence. A single
and of the expected size was detected with each set of
rimers. No bands were detected when RT-PCR was per-
ormed without reverse transcriptase (data not shown).
wenty-seven cycles was determined to be within the
inear range of both Slug and GAPDH amplification by
emoving and analyzing aliquots from a series of cycles
FIG. 3. TGFb2 did not rescue the inhibitory effect of retinoic ac
xplants were cultured on collagen gels in the presence of retinoic
ncubation, the number of mesenchymal cells within the collag
ombination of retinoic acid and TGFb2 resulted in a statistically si
o untreated explants or explants treated with only TGFb2. ErrorCopyright © 2000 by Academic Press. All right20–35). RT-PCR was then repeated for 27 cycles using
NA collected from both untreated and treated explants.
uantification of Slug band density normalized to GAPDH
evels from the same RNA samples demonstrated that only
reatment with anti-TGFb2 antibody or retinoic acid re-
sulted in a statistically significant decrease in Slug mRNA
expression compared to untreated explants (Fig. 6).
We also performed immunostaining to show that treat-
ment with anti-TGFb2 antibody or retinoic acid resulted in
a decrease in Slug protein expression. After 24 h of incuba-
tion, the explants were stained with a monoclonal anti-
chicken Slug antibody. The AV canal endothelial cells of
untreated explants express Slug, as do mesenchymal cells
within the collagen gel (Fig. 7B). However, staining was
reduced within the endothelium of explants treated with
anti-TGFb2 antibody or retinoic acid (Figs. 7B and 7C). No
taining was observed when explants were stained for
ouse IgG as a negative control (Fig. 7A).
Slug Rescues the Inhibitory Effect of Anti-TGFb2
ntibody but Not Retinoic Acid on Epithelial–
esenchymal Cell Transformation
Treatment of AV canal explants with anti-TGFb2 anti-
body or retinoic acid inhibited Slug expression, suggesting
that Slug is either directly or indirectly regulated by these
signaling factors. We proceeded to test whether Slug is
sufficient to overcome the inhibitory effect of anti-TGFb2
epithelial–mesenchymal cell transformation. Stage 14 AV canal
alone or a combination of retinoic acid and TGFb2. After 24 h of
el was counted for each explant. Treatment of explants with a
cant (P , 0.05) decrease in mesenchymal cell formation compared
ndicate the standard errors.id on
acid
en g
gnifi
bars is of reproduction in any form reserved.
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97Slug and TGFb2 in the Heartantibody or retinoic acid on initial steps of EMT. AV canals
were dissected from stage 14 embryonic chicken hearts and
transfected with a plasmid encoding full-length Slug and
GFP (green fluorescent protein) (Fig. 8). The plasmid was
preincubated with Lipofectamine to facilitate delivery into
the cells. The transfected tissue was then cultured on
collagen gels in the presence of anti-TGFb2 antibody or
retinoic acid. After 48 h of incubation, the number of
mesenchymal cells within the collagen gel was counted for
each explant.
Slug partially rescued the inhibitory effect of anti-TGFb2
ntibody but not retinoic acid on EMT (Fig. 9). In the
FIG. 4. Noggin, an antagonist of BMP signaling, inhibited later
steps of epithelial–mesenchymal cell transformation. Stage 13, 14,
15, or 16 AV canal explants were cultured on collagen gels in
noggin-containing or control conditioned medium. After 24 h of
incubation, the number of mesenchymal cells within the collagen
gel was counted for each explant. Noggin had no significant effect
on mesenchymal cell formation in stage 13, 14, or 15 explants.
However, treatment of stage 16 AV canal explants with noggin
resulted in a statistically significant (P , 0.05) decrease in
esenchymal cell formation compared to untreated explants or
xplants cultured in control conditioned medium. The inhibitory
ffect of noggin on stage 16 explants was rescued by the addition of
xogenous BMP-2. Error bars indicate the standard errors.Copyright © 2000 by Academic Press. All rightwith Slug resulted in approximately 28% more mesenchy-
mal cells than explants transfected with control plasmid. In
contrast, in the presence of retinoic acid there was no
significant difference between explants transfected with
Slug and explants transfected with control plasmid. There-
fore, Slug is sufficient to overcome the inhibitory effect of
anti-TGFb2 antibody but not retinoic acid on initial steps of
MT.
DISCUSSION
The transcription factor Slug is required for initial steps
of the EMT which occur during endocardial cushion forma-
tion (Romano and Runyan, 1999). In the present study, we
sought to identify signaling factors that regulate Slug ex-
pression in the heart in an effort to establish a pathway of
genes required for EMT.
Several signaling factors are required for initial steps of
EMT and, therefore, could potentially regulate Slug expres-
sion in the heart. For instance, TGFb2 and Gi proteins are
required for AV canal endothelial cells to undergo initial
steps of EMT. Treatment of AV canal explants with anti-
TGFb2 antibody or pertussis toxin, an antagonist of Gi
protein signaling, inhibited initial steps of EMT including
endothelial cell–cell separation (Boyer et al., 1999a; Runyan
et al., 1990). Retinoic acid also was a good candidate for
regulating Slug expression in the heart. Retinoic acid, the
metabolically active form of vitamin A, alters gene expres-
sion by binding to retinoic acid receptors and retinoid X
receptors (RXRs), members of the steroid superfamily of
ligand-activated transcription factors (reviewed by Cham-
bon, 1996). RXRa 2/2 mouse embryos exhibit AV septal
defects (Gruber et al., 1996). Likewise, AV septal defects
arise when embryos are exposed to inappropriate levels of
retinoic acid (reviewed by Smith et al., 1998). In this study,
we found that treatment of AV canal explants with retinoic
acid inhibited initial steps of EMT, including endothelial
cell–cell separation, consistent with the fact that fewer
mesenchymal cells were found within the endocardial
cushions of chicken embryos exposed to retinoic acid
(Bouman et al., 1998). Recent findings suggest that retinoic
acid inhibits EMT by interfering with the inductive signal
provided by AV canal myocardium (Yan et al., 2000).
etinoic acid also may directly affect the expression of
enes in the AV canal endothelium.
Additional signaling factors are required for EMT in the
eart. For instance, TGFb3 is required for later steps of
EMT including mesenchymal cell transformation (Boyer et
al., 1999a). BMP and HGF signaling also are required for
EMT. BMPs are members of the TGFb superfamily of
elated growth factors. BMP-2 is expressed in the AV canal
yocardium of chicken embryos (Yamagishi et al., 1999).
reatment of AV canal explants with an antisense BMP-2
ligodeoxynucleotide inhibited EMT (Yamagishi et al.,
999). Recently, Nakajima et al. (2000) demonstrated that a
ombination of TGFb3 and BMP2 stimulated competents of reproduction in any form reserved.
H
T
t
o
i
e
c
e
c
H
i
m
f
a
S
t
T
u
c
N
t
b
p
s
a
T
T
w
t
o
d
w
98 Romano and Runyanendothelial cells to undergo EMT. As pharmacological
doses of any TGFb isoform can mediate EMT (Potts and
Runyan, 1989; Nakajima et al., 1998), the significance of a
particular TGFb isoform in this combination is limited.
owever, these data show a synergy between one or more
GFbs and BMP. In the present study, we found that
reatment of AV canal explants with noggin, an antagonist
f BMP signaling, inhibited only later steps of EMT, includ-
ng mesenchymal cell migration. The growth factor HGF is
xpressed in AV canal myocardium while its receptor,
-Met, is expressed in AV canal endothelium. AV canal
ndothelial cells cultured in vitro in the absence of AV
anal myocardium undergo EMT in response to exogenous
GF (Song et al., 1999). This is accompanied by an increase
n the expression of urokinase, a protease implicated in cell
otility and migration (McGuire and Alexander, 1993). We
ound that treatment of AV canal explants with anti-HGF
ntibody also inhibited later steps of EMT.
Treatment of AV canal explants with anti-TGFb3 anti-
body, noggin, or anti-HGF antibody did not inhibit Slug
expression, consistent with the finding that these signaling
factors are required only for later steps of EMT in the heart.
However, BMP and HGF signaling have been shown to
regulate Slug expression in other tissues. BMP signaling
from adjacent nonneural ectoderm regulates Slug expres-
sion in the neural crest of chicken embryos (Liem et al.,
1995; Selleck et al., 1998). Previous work demonstrated that
FIG. 5. Anti-HGF antibody inhibited later steps of epithelial–mes
ere cultured on collagen gels in the presence of anti-HGF antibo
he collagen gel was counted for each explant. Anti-HGF antibody h
r 16 explants. However, treatment of stage 17 AV canal explants w
ecrease in mesenchymal cell formation compared to untreated ex
as rescued by the addition of exogenous HGF. Error bars indicateCopyright © 2000 by Academic Press. All rightlug also is a downstream target of HGF signaling during
he transformation of rat NBT-II bladder carcinoma cells.
he addition of exogenous HGF can induce NBT-II cells to
ndergo EMT in vitro. NBT-II cells transfected with Slug
DNA completed initial steps of transformation. However,
BT-II cells transfected with antisense Slug cDNA did not
ransform into mesenchymal cells and resisted induction
y HGF (Savagner et al., 1997). Although Slug appears to
lay a conserved role in EMT, these data suggest that the
ignaling factors that regulate Slug expression during EMT
re tissue-dependent.
We found that only treatment of explants with anti-
GFb2 antibody or retinoic acid inhibited Slug expression.
hese data are consistent with the fact that TGFb2 is
required along with Slug for initial steps of EMT. In
addition, they are consistent with the fact that retinoic acid
was shown in this study to inhibit initial steps of EMT.
Retinoic acid has been shown to inhibit Slug expression in
the chicken limb bud as well. Within the limb bud, Slug is
expressed in the progress zone, an area of undifferentiated,
rapidly proliferating mesenchymal cells subjacent to the
apical ectodermal ridge (Buxton et al., 1997; Ros et al.,
1997). Implantation of retinoic acid beads inhibited Slug
expression in the progress zone (Buxton et al., 1997). It is
interesting to note that neural crest defects are associated
with exposure of embryos to abnormal levels of retinoic
acid (reviewed by Smith et al., 1998). It is possible that
ymal cell transformation. Stage 14, 15, 16, or 17 AV canal explants
fter 24 h of incubation, the number of mesenchymal cells within
o significant effect on mesenchymal cell formation in stage 14, 15,
nti-HGF antibody resulted in a statistically significant (P , 0.05)
s. The inhibitory effect of anti-HGF antibody on stage 17 explants
standard errors.ench
dy. A
ad n
ith a
plant
thes of reproduction in any form reserved.
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99Slug and TGFb2 in the Heartretinoic acid also disrupts Slug expression in presumptive
neural crest cells, including those that contribute to the
outflow tract region of the heart.
Transfection of AV canal explants with Slug did not
rescue the inhibitory effect of retinoic acid on EMT. Slug
may not have been sufficient to overcome the inhibitory
effect of retinoic acid on EMT because it was only one of
FIG. 6. Anti-TGFb2 antibody or retinoic acid inhibited Slug mR
performed using RNA collected from untreated explants; stage 1
ertussis toxin, or retinoic acid; stage 16 explants cultured in noggin
ith anti-HGF antibody. Treatment of explants with anti-TGFb2 a
decrease in Slug mRNA expression compared to untreated explant
FIG. 7. Anti-TGFb2 antibody or retinoic acid inhibited Slug prote
of an untreated stage 14 AV canal explant cultured on a collagen ge
canal endothelial cells of an untreated explant stained for Slug. The
collagen gel express Slug. (C) The AV canal endothelial cells of an
AV canal endothelial cells of an explant treated with retinoic acid
reduced in the presence of anti-TGFb2 antibody or retinoic acid.Copyright © 2000 by Academic Press. All righteveral genes disrupted by retinoic acid exposure. Exposure
f embryos to abnormal levels of retinoic acid appears to
ave a widespread effect on gene expression. For instance,
bnormal levels of retinoic acid have been shown to disrupt
he development of many tissues, including the neural
rest, heart, eyes, limbs, and nervous system (reviewed by
mith et al., 1998). The recent demonstration that retinoic
expression in AV canal explants. Semiquantitative RT-PCR was
plants treated with anti-TGFb2 antibody, anti-TGFb3 antibody,
taining or control conditioned medium; or stage 17 explants treated
dy or retinoic acid resulted in a statistically significant (P , 0.05)
ror bars indicate the standard errors (N 5 4).
pression in AV canal explants. (A) The AV canal endothelial cells
24 h and stained for normal IgG as a negative control. (B) The AV
anal endothelial cells as well as the mesenchymal cells within the
nt treated with anti-TGFb2 antibody and stained for Slug. (D) The
stained for Slug. Staining within the AV canal endothelium wasNA
4 ex
-con
ntibo
s. Erin ex
l for
AV c
expla
ands of reproduction in any form reserved.
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100 Romano and Runyanacid disrupts ECM secretion by the myocardium suggests
that expression of Slug is unable to overcome the loss of one
or more components of the inductive signal provided by the
myocardium (Yan et al., 2000).
FIG. 8. A plasmid encoding full-length Slug and GFP was con-
structed to rescue AV canal explants treated with anti-TGFb2
ntibody or retinoic acid. Full-length Slug cDNA (829 bp) was
loned into the Clontech bicistronic expression vector pIRES2-
GFP (5.3 kb) using EcoRI and BamHI restriction enzymes. This
ector permits both Slug and EGFP to be translated from a single
NA due to the presence of an internal ribosome entry site (IRES).
FIG. 9. Slug rescued the inhibitory effect of anti-TGFb2 antibody
AV canals were dissected from stage 14 chicken embryo hearts an
explants were incubated for 48 h on collagen gels in the presence of a
within the collagen gel was then counted for each explant. Transfec
in mesenchymal cell formation (P , 0.05) in the presence of anti-T
No significant difference was observed between explants transfe
presence of retinoic acid.Copyright © 2000 by Academic Press. All rightffect of anti-TGFb2 antibody on EMT. Therefore, Slug
appears to be an essential target of TGFb2 signaling during
initial steps of EMT in the heart. TGFb2 signaling may
egulate Slug expression through activation of the Type III
GFb receptor. Treatment of AV canal explants with a
blocking antibody specific for the Type III TGFb receptor
inhibited initial steps of EMT (Brown et al., 1999). In
contrast, treatment of AV canal explants with a blocking
antibody specific for the Type II TGFb receptor inhibited
istinctly later steps of EMT (Brown et al., 1996). Thus,
TGFb2 appears to regulate initial steps of EMT via activa-
ion of the Type III TGFb receptor, while TGFb3 appears to
egulate later steps of EMT via activation of the Type II
GFb receptor. The Type III TGFb receptor, also known as
etaglycan, has no known signaling domain (Wang et al.,
991; Lopez-Casillas et al., 1991) and was presumed only to
“present” ligand to other TGFb receptors (Lopez-Casillas et
al., 1993). However, recent work suggests that the Type III
TGFb receptor is capable of signal transduction (Brown et
al., 1999). Regulation of Slug expression by TGFb2 but not
TGFb3 demonstrates the ability of target AV canal endo-
helial cells to distinguish between the different endoge-
ous TGFb signal transduction pathways involved in EMT
and is consistent with the suggestion of regulation by
betaglycan. This pattern of ligand and receptor activity (i.e.,
not retinoic acid on epithelial–mesenchymal cell transformation.
nsfected with a plasmid encoding full-length Slug and GFP. The
GFb2 antibody or retinoic acid. The number of mesenchymal cells
of explants with Slug resulted in a statistically significant increase
antibody, compared to explants transfected with control plasmid.
with Slug and explants transfected with control plasmid in thebut
d tra
nti-T
tion
GFb2
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101Slug and TGFb2 in the HeartType II receptor) is further demonstrated by specific regu-
lation of a variety of markers in cardiac cushion develop-
ment (Boyer et al., 1999b; Boyer et al., in preparation).
In summary, several signaling factors are expressed in the
V canal and are required for EMT. Previous studies along
ith data presented here indicate that these signaling
actors are required for specific steps of EMT (Boyer et al.,
999a). TGFb3, BMP, and HGF signaling is required for
later steps of EMT. In contrast, TGFb2 and Gi protein
signaling is required along with Slug for initial steps of
EMT. Our data indicate that AV canal endothelial cells are
also sensitive to retinoic acid during initial steps of EMT.
However, only TGFb2 and retinoic acid were shown to
egulate Slug expression in the heart. Although Gi protein
signaling is required along with Slug for initial steps of
EMT, pertussis toxin failed to inhibit Slug expression. The
signaling factors involved in initial steps of EMT thus
appear to regulate the expression of different or overlapping
sets of genes. Additional studies are necessary to identify
specific G protein-linked receptors and their downstream
targets in the heart.
These data contribute to a model in which AV canal
endothelial cells undergo EMT in response to multiple,
independent signaling pathways. Identification of addi-
tional components of these signal transduction pathways
will contribute to a better understanding of EMT. For
instance, several transcription factors including Brachyury,
Msx-1, and Mox-1 are expressed in the heart and have been
shown to play a role during EMT in other tissues (reviewed
by Huang et al., 1995). One or more of these transcription
factors may be required along with Slug for the EMT which
occurs in the AV canal. Future studies of EMT also appear
to be critical for understanding metastasis. Interestingly,
Snail, a transcription factor related to Slug, was recently
shown to repress the expression of E-cadherin in invasive
carcinoma tissues in mouse embryos (Batlle et al., 2000;
Cano et al., 2000).
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